News
GSK Plc won US approval for its drug to treat a deadly lung disease, ramping up competition with rival Sanofi.
The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and ...
FDA approves Dupixent as the first new CSU treatment in over a decade. 2. Phase 3 trial shows significant symptom reduction ...
Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also ...
Corticosteroids are potent drugs used to reduce inflammation in the body's tissues. They are different from anabolic steroids. These are illegally used by some athletes to increase muscle tone.
Ashley Lora joined an eczema clinical trial for DUPIXENT and paved the way for other Black women to try clinical trials.
Detailed price information for Apogee Therapeutics Inc (APGE-Q) from The Globe and Mail including charting and trades.
Dupixent (dupilumab) Interleukin-4 receptor alpha antagonist Treatment of patients aged 12 years and older with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.
It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results